Videos | Cath Lab | March 31, 2021
This is a quick example of clinical use of the Shockwave Medical Intravascular Lithotripsy system that uses sonic wave...
Researchers found a relationship between stress-associated neurobiological activity on 18F-FDG PET-CT imaging and risk for subsequent Takotsubo syndrome impacting the heart.

Researchers found a relationship between stress-associated neurobiological activity on 18F-FDG PET-CT imaging and risk for subsequent Takotsubo syndrome impacting the heart.

News | March 31, 2021
March 31, 2021 — Heightened activity in the brain, caused by stressful events, is linked to the risk of developing a...
cImage Inc. celebrates its cloud partnership with Digirad Health after a year of successful deployment of PICOM365 for mobile imaging. Digirad’s fleet of mobile SPECT, echocardiology, vascular and general ultrasound units combined with PICOM365’s cloud image management workflow leverage each company’s strengths to create an exemplary reading and reporting environment.
News | Cardiac Imaging | March 31, 2021
March 31, 2021 — ScImage Inc. celebrates its cloud partnership with Digirad Health after a year of successful...
Driven by pandemic realities and clinical demand for portable and intelligent point-of-care ultrasound (POCUS), GE Healthcare unveiled Venue Fit, a streamlined and compact POCUS system, alongside an industry-first artificial intelligence (AI) offering for cardiac imaging on the Venue and Venue Go. The Venue Fit is the smallest system in GE Healthcare’s Venue Family, featuring an easy-to-clean touchscreen, intuitive scanning tools, and a small footprint designed to fit in tight spaces often found in point-of
News | Point-of-Care Ultrasound (POCUS) | March 31, 2021
March 31, 2021 — Driven by pandemic realities and clinical demand for portable and intelligent point-of-care ultrasound...
The Medtronic Harmony Transcatheter Pulmonary Valve (TPV) System. It is first in the world non-surgical heart valve to treat pediatric and adult patients with a native or surgically-repaired right ventricular outflow tract (RVOT) to stop severe pulmonary valve regurgitation caused by congenital heart disease.

The Medtronic Harmony Transcatheter Pulmonary Valve (TPV) System is is designed for patients without a conduit with RVOT malformations who require a correction to their structural malformation early in life and need a minimally invasive option to restore pulmonary valve function.
 

Feature | Structural Heart | March 26, 2021 | By Dave Fornell, Editor
March 26, 2021 — Today, the U.S. Food and Drug Administration (FDA) cleared the Medtronic Harmony Transcatheter...
The March April 2021 issue of DAIC, Diagnostic and Interventional Cardiology magazine, Dave Fornell is the editor.
Feature | March 26, 2021
View the March-April 2021 digital edition of Diagnostic and Interventional Cardiology (DAIC) magazine, include links to...
Virtual tour views of a University of Colorado cath lab during a CTO procedure (top left), the new robotic EP lab at Banner Health (top right), a bi-plane EP/cath combo lab at Baylor Heart Hospital Dallas (bottom left, and an ECMO procedure at Tufts Medical Center cath lab. Photos by Dave Fornell

Virtual tour views of a University of Colorado cath lab during a CTO procedure (top left), the new robotic EP lab at Banner Health (top right), a bi-plane EP/cath combo lab at Baylor Heart Hospital Dallas (bottom left, and an ECMO procedure at Tufts Medical Center cath lab. Photos by Dave Fornell, except the Banner EP lab, by Peter Weiss, M.D.

Feature | March 25, 2021
There is a lot of interest in how other hospitals organize and equip their cardiac cath labs and electrophysiology (EP...
Neonates and young pediatric patients with congenital heart disease have few options for implantable electrophysiology (EP) devices like pacemakers or ICDs.
News | Congenital Heart | March 24, 2021
March 24, 2021 — Congenital heart disease (CHD) affects six out of 1,000 babies born in the U.S. each year and is often...
PA pressure-guided heart failure management is fast becoming the standard of care in NYHA Class III patients. The Cordella Pulmonary Artery Pressure Sensor enables clinicians to remotely monitor and proactively adjust therapy and medications remotely without the need for office visits.

PA pressure-guided heart failure management is fast becoming the standard of care in NYHA Class III patients. The Cordella Pulmonary Artery Pressure Sensor enables clinicians to remotely monitor and proactively adjust therapy and medications remotely without the need for office visits.

News | Heart Failure | March 24, 2021
March 24, 2021 — Endotronix Inc., a digital health and medical technology company working on advancements in treating...
Videos | Structural Heart | March 23, 2021
Interview with Scott E. Kasner, M.D., who served as the principle investigator for the Gore Cardioform REDUCE trial,...
Top left, electromechanical wave imaging (EWI) isochrone renderings showing the activation points of the myocardium based on echocardiography axial strain measurements. Bottom right, EWI images overlaid on patient's CT scan of the heart.

Top left, electromechanical wave imaging (EWI) isochrone renderings showing the activation points of the myocardium based on echocardiography axial strain measurements. Bottom right, EWI images overlaid on patient's CT scan of the heart.

News | EP Lab | March 23, 2021
March 23, 2021 — Researchers at Columbia University are using cardiac ultrasound to improve the critical need to...
Early detection of high-risk plaque phenotypes holds the promise to prevent myocardial infarction and ischemic stroke by enabling personalized therapeutics. The company Elucid has developed AI to identify these atherosclerotic plaque phenotypes from a CT scan.

Early detection of high-risk plaque phenotypes holds the promise to prevent myocardial infarction and ischemic stroke by enabling personalized therapeutics. The company Elucid has developed AI to identify these atherosclerotic plaque phenotypes from a CT scan.

News | CT Angiography (CTA) | March 23, 2021
March 23, 2021 — Researchers at the Karolinska Institute in Stockholm, Sweden, have published the first-of-its-kind...
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) can potentiate all 3 sides of Virchow’s Triad of coagulopathy, including endothelial dysfunction, blood flow stasis, and hypercoagulability. Angiotensin-converting enzyme-2 (ACE-2)–dependent viral entry and the virus-induced inflammatory response can lead to endothelial dysfunction. Clotting Prevention in COVID-19 Patients, Thrombosis Prevention in COVID-19 Patients, Preventing blood clots in COVID-19 patients

Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) can potentiate all 3 sides of Virchow’s Triad of coagulopathy, including endothelial dysfunction, blood flow stasis and hypercoagulability. Angiotensin-converting enzyme-2 (ACE-2)–dependent viral entry and the virus-induced inflammatory response can lead to endothelial dysfunction. Additional figure included in the JACC article.

Feature | Antiplatelet and Anticoagulation Therapies | March 22, 2021 | By Dave Fornell, Editor
A comprehensive review or more than 80 randomized controlled trials (RCTs) investigating how to best manage optimal...
Videos | Ventricular Assist Devices (VAD) | March 22, 2021
Surgeons at Penn State Heart and Vascular Institute were the second group in the nation to implant a newly-designed...
University of Minnesota researchers used a hybrid of tissue engineering and regenerative medicine to create heart valves that can grow with the recipient. When implanted in lambs, researchers showed that the tri-tube valves worked better than current animal-derived valves with almost none of the calcification or blood clotting that the other valves showed. This can be implanted in pediatric patients with congenital heart diseas. Photo from Syedain, et al., Tranquillo Lab, University of Minnesota

University of Minnesota researchers used a hybrid of tissue engineering and regenerative medicine to create heart valves that can grow with the recipient. When implanted in lambs, researchers showed that the tri-tube valves worked better than current animal-derived valves with almost none of the calcification or blood clotting that the other valves showed. Photo from Syedain, et al., Tranquillo Lab, University of Minnesota

News | Heart Valve Technology | March 18, 2021
March 18, 2020 — A groundbreaking new study led by University of Minnesota Twin Cities researchers from both the...